JPM vs MRK: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Merck & Co., Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-14.
JPMorgan Chase & Co. · Financial Services
$334.53
+45.0% upside to fair value
Grade B
High Quality
VS
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
QuantHub Verdict
JPM has more upside to fair value
(+45.0%).
JPM trades at a lower forward P/E
(14.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
MRK |
| Current Price |
$334.53 |
$113.87 |
| Fair Value Estimate |
$485.07 |
$100.14 |
| Upside to Fair Value |
+45.0%
|
-12.1%
|
| Market Cap |
$896.4B |
$281.2B |
| Forward P/E |
14.3x
|
32.0x
|
| EV / EBITDA |
12.4x
|
17.3x
|
| Price / Sales |
5.4x
|
4.3x
|
| Price / FCF |
6.4x
|
19.9x
|
| Revenue Growth YoY |
-168.4%
|
+4.3%
|
| Gross Margin |
78.6%
|
75.9%
|
| Operating Margin |
33.7%
|
27.6%
|
| Return on Equity |
17.8%
|
17.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
15.72%
|
5.02%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
JPMorgan Chase & Co. operates as a leading diversified bank within the financial services sector, demonstrating a high-quality business model characterized by a strong return on equity of 17.8% and robust profitability margins including a net margin of 38.9%. Despite a significant revenue decline of 168.4% year-over-year in the most recent quarter, earnings grew by 41.2%, reflecting operational e…
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Accumulation Zones
| Metric |
JPM |
MRK |
| Zone Low |
$363.80 |
$75.11 |
| Zone High |
$412.31 |
$85.12 |
| In Buy Zone? |
Yes
|
No
|